Practical guidelines for initiation of beta-adrenergic blockade in patients with chronic heart failure.
Recent developments in the treatment of chronic heart failure have lead to the use of beta blockers to improve ventricular function and symptoms, and to reverse or slow pathologic remodeling of the failing heart. Little practical information exists in the literature on how to initiate this therapy and how to select the proper beta-blocking agent. This editorial examines which beta-blocking agents are best tolerated and why, and describes how best to initiate treatment with these agents.
Eichhorn
E J
EJ
Bristow
M R
MR
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000494:pharmacology; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D017410:Practice Guidelines as Topic
D000319:Adrenergic beta-Antagonists